Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Today’s Research Excellence Framework (REF 2014) results confirm the University of Oxford’s world leading position in medical sciences research.

The Department of Physiology, Anatomy & Genetics formed part of the University’s REF return under the Biological Sciences unit of assessment and we are delighted that out of the 44 institutions making a return under this unit of assessment, Oxford returned the greatest volume of world leading (4*) ranked activity.

Read more on the University's website and on the Medical Sciences Division's website

Similar stories

REF 2021 results

Nobel Laureate Professor Thomas Südhof ForMemRS delivers 2022 Sherrington Prize Lecture

The annual lecture was given in honour of Sir Charles Sherrington, who was awarded the 1932 Nobel Prize in Physiology or Medicine, by the 2013 Nobel Laureate in Physiology or Medicine.

Professor David Paterson unveils Blue Plaque to honour Sir Charles Sherrington at his long-time Oxford residence

Head of Department Professor David Paterson unveiled an Oxfordshire Blue Plaque commemorating Sir Charles Scott Sherrington (1857 – 1952), OM, Nobel Laureate, founder of neurophysiology, on Thursday 28 April at 9 Chadlington Road, Oxford.

Oxford Parkinson’s Disease Centre awarded £3.8 million to reveal the role of calcium in Parkinson’s

A collaborative research team led by the Oxford Parkinson’s Disease Centre (OPDC) has been awarded a £3.8 million Wellcome Trust Collaborative Award to study the function of calcium in dopamine neurons, and how this is plays a role in Parkinson’s. Their research will help explain how and why dopamine neurons are vulnerable in the disease and look at how they may be preserved.

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.